Nick van Dijk

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial

Nick van Dijk, Alberto Gil-Jimenez, Karīna Siliņa et al. · Nature Medicine · 2020 · 385 citations

Urology, Oncology, Genitourinary Cancer +7

Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer

Bernadett Szabados, Nick van Dijk, Yen Zhi Tang et al. · European Urology · 2017 · 132 citations

Metastatic Urothelial Cancer, Urology, Genitourinary Cancer +9

<i>Escherichia coli</i> –Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer

Anne‐Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva et al. · Cancer Discovery · 2022 · 70 citations · Full text

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial

Jeroen van Dorp, Christodoulos Pipinikas, Britt B.M. Suelmann et al. · Nature Medicine · 2023 · 70 citations · Full text

Phase 1B, Urology, Genitourinary Cancer +8

Clinical outcome after progressing to frontline and second-line Anti–PD-1/PD-L1 in advanced urothelial cancer

Alfonso Gómez de Liaño, Nick van Dijk, Guillermo de Velasco et al. · European Urology · 2019 · 61 citations

Urology, Genitourinary Cancer, Medicine +8